SUMMARY Plasma antithrombin levels were measured by clotting, immunological, and amidolytic methods on two groups of subjects: 20 normal individuals and nine patients studied serially postoperatively (hip replacement). The postoperative patients were observed for the emergence of deep-vein thrombosis using 1251-fibrinogen uptake measurements (FUT).
The three methods gave similar ranges for the normal subjects, were reproducible (cv < 5 %), and detected early postoperative reduction of antithrombin levels. All three methods failed to show any significant differences in preoperative antithrombin levels between the positive and negative FUT groups.
Correlation studies were performed on the pooled data from the normal and postoperative group (range 60-130% of normal; 100 samples). The best correlation (r = 0 75; P < 0 01) was achieved with the chromogenic kit assay method versus the Mancini immunoassay technique. The thrombin agarose (total antithrombin) gel diffusion technique correlated less well with the chromogenic (r = 0-65; P < 0.01) and Mancini immunoassay (r = 0 45; P < 0 01) methods. It is concluded that the chromogenic kit method gives a rapid, reproducible, and specific measurement of antithrombin III. The thrombin agarose diffusion method, though not specific for antithrombin III, is a cheap and simple method to perform. The potential of the three methods for detecting the prethrombotic stage and early thrombosis is discussed.
Current interest in the relationship between thrombosis and antithrombin levels is complexed by the variety of methods available for the measurement of this natural anticoagulant' and the variable reliability of methods for the detection of thrombosis. 2 Comparisons of clotting methods with immunoassays for the measurement of plasma antithrombin levels have at times given conflicting results. Bounameaux et al.3 showed no significant correlation between two clotting methods and two immunoassay procedures. In contrast, Frigola4 and Abildgaard et al.5 showed good correlation (r = 0-8).
The emergent amidolytic methods claim to measure antithrombin III activity specifically, and have previously been shown to correlate well with both immunoassay and clotting procedures.6-8
Gaffney et al. 9 have, however, shed some doubts on *Present address: Princess Elizabeth Orthopaedic Hospital, Wonford Road, Exeter, Devon. Received for publication 12 November 1979 the specificity of artificial chromogenic substrates in experiments with degraded thrombin preparations.
Variable loss of antithrombin components and altered method precision after defibrination-via heating, clotting, or Arvin treatment-have been reported.6 8 10 The validity of comparing 'defibrinated' clotting methods with 'plasma' antithrombin methods is therefore dubious.
In this study the total progressive antithrombin assay method of Lane et The chromogenic substrate S-2238, in the presence of polybrene, was used as the substrate for residual thrombin. p-Nitralinine (p-NA) released from the substrate H-D-Phe-Pip-Arg-p-NA was measured photometrically at 405 nm using the end-point procedure (ie, stopping the reaction at 30 seconds with 500% acetic acid).
The amount of thrombin inhibited by the antithrombin III-heparin complex is proportional to the amount of antithrombin III present.
DETECTION OF DEEP VEIN THROMBOSIS
(1) One hundred milligrams of KI was given orally 24 hours preoperatively and 100 ,Ci of 1251-fibrinogen was given intravenously at least 4 hours preoperatively. Radioactivity was measured over the operated leg from mid-thigh and over the other leg from groin to ankle at 2 in (5 cm) intervals, and readings were expressed as a percentage of the reading over the heart. Measurements were done on the day before operation and daily thereafter for at least five days except in the case of patient 4, in whom only four postoperative measurements were made. A positive FUT scan was recorded when the reading was raised by 25% over that of the previous day and maintained for more than 24 nations were performed on the normal subject group. Figure 4 shows that the correlation between the chromogenic substrate and immunoassay methods is very good (r = 0 85; P < 0 01). The TAD method correlated badly with both the immunoassay (r = 0-013, not significant) and chromogenic substrate (r = 0 055, not significant) methods.
METHOD PRECISION
A limited replication analysis was performed to examine whether the poorer correlation of the TAD method could be explained by differences in method precision. The results are shown in Table 2 . These results indicate that all methods have an acceptable
The replicates on the chromogenic and immunoassay methods were day-to-day, while the data on the TAD method comprised eight replicates on each of three plates (ie, intra and inter assay). POSTOPERATIVE 
STUDIES
Daily antithrombin values were measured before operation and serially postoperatively using the three methods. All of the patients had preoperative values within the normal range when measured by the chromogenic substrate and immunodiffusion methods. Two patients (1 and 9) had slightly y 33-06+074x elevated levels by the TAD method (see Table 3 ).
The mean changes in antithrombin from the P -<0'°1 baseline for each day, using each method, are shown 125 150% in Figure 5 . These results demonstrate a significant OASSAY reduction in antithrombin by all three methods on diffusion the first day after operation. Student's paired t test ne denotes gave P < 0-01 for both the chromogenic substrate and Mancini immunoassay methods and P = 0 02 for the TAD method. Table 3 ).
Discussion
The above results show that the three methods The significant but poorer correlation of the TAD method with the other two methods could result from reduced assay precision or specificity differences of the assay. In view of the demonstrated adequate precision of the TAD method ( Table 2) the second mechanism appears the more likely. Lane et al.," using the TAD method, showed that the method measures a2-macroglobulin and ai-antitrypsin in addition to the antithrombin III-a2-globulin component of total progressive antithrombin. Using immunoadsorption experiments, it was shown that total progressive antithrombin comprises 47% antithrombin III, 29% a2-macroglobulin, and 26% ai-antitrypsin. It must be pointed out that Lane's figures were produced using bovine thrombin, as have most of the reported studies on clotting procedures. In our experiments, human thrombin was used, which, although less sensitive than bovine thrombin in terms of inhibition zone size, appeared the more suitable regarding specificity. The use of human thrombin does not appear to have adversely affected the precision of the assay.
Previous studies of antithrombin levels in postoperative patients have given varying results. Stathakis et aL.l5 demonstrated significantly reduced levels in 39 patients undergoing major abdominal surgery. Conversely, Donati et al.'7 reported no significant alteration in 17 patients undergoing hysterectomy. The consensus, however, indicates a significant drop in levels from day 1 after operation, returning by day 8 to baseline.16 Our findings confirm this view, although in our study baseline values were reattained by the fourth day after operation. It is possible that the differences in reported studies may, in part, be attributable to differences in the site and extent of the operative procedure.
Immunological methods for measuring antithrombin III have been shown to be insensitive to reductions in biological activity of the protein in certain situations. Sas et al., '8 Theoretically, the less specific total antithrombin method might be expected to give the better index of thrombosis in the postoperative situation. This is because the a2-macroglobulin component contributes significantly to antiplasmin activity, which has been reported to be reduced in the immediate postoperative period,2' and might therefore augment the antithrombin III drop in the thrombotic situation.
Similarly, al-antitrypsin, an acute phase reactant, might be expected to augment the secondary rise of antithrombin III. It is, therefore, interesting that a significant difference in postoperative values between day 1 and day 4 was noted for the positive FUT group using the TAD method. This significant finding is a compound of three trends: the apparent greater drop of antithrombin by day 1, the more rapid increase, and the 'rebound' effect, elements which in isolation failed to achieve significance.
The number of postoperative patients studied in this pilot project is too small for reliable statistical conclusions to be drawn. However, the limited findings generally support the conclusions of a recent major trial,22 which showed that antithrombin III estimations in individual patients are unlikely to be of great value in the early detection of thrombosis. The value of the total antithrombin method should be reassessed as part of a larger study.
In practical terms, the chromogenic substrate (S-2238) kit method has the advantages of rapid reproducible measurement of antithrombin III using a colorimetric end-point system, with the option of automating the method. However, the method would require routine regular usage to justify the costs of the labile reagents. The Mancini immunoassay is slightly cheaper to perform than the unmodified chromogenic method, although the end-point takes longer to develop-not always a disadvantage. The possibility of measuring nonactive antithrombin III proteins restricts the use of this method. The thrombin-agarose gel diffusion method is straightforward procedurally and the cheapest of the techniques to perform. It, too, has the debatable disadvantage of an overnight incubation delay in achieving an end-point. The method's lack of specificity for antithrombin III may have clinical advantages as outlined.
